Targeting silent brain infarcts to improve neurologic outcomes in iTTP
Official title: Targeting silent cerebral infarction to improve long-term neurologic outcomes in immune thrombotic thrombocytopenic purpura (iTTP)
Funded at Johns Hopkins University · NIH-11399793 · Data updated 2026-11-12
A multi-center study looks at hidden brain injuries in adults with immune thrombotic thrombocytopenic purpura (iTTP) and what it means for their long-term brain health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | August 27, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $394,571 |
| NIH project number | 5R00HL172303-03 |
| Project ID | NIH-11399793 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with immune thrombotic thrombocytopenic purpura (iTTP), including those in remission, who are willing to undergo MRI and cognitive assessments.
✕Less likely to help
Patients who cannot undergo MRI or participate in long-term follow-up may not benefit from this study.
What this research studies
People living with iTTP may have silent brain injuries that aren’t obvious yet can affect thinking and increase stroke risk. This project will follow several patient groups across three major medical centers to map how these silent injuries develop over time, whether they predict future strokes, and how we might prevent them. Researchers will use MRI to identify silent cerebral infarctions and correlate findings with cognitive function and stroke risk. The study builds on prior work and aims to translate observations into better monitoring and prevention for patients with iTTP.
Why it matters
Potential benefit: If successful, patients with iTTP could receive better monitoring and strategies to prevent cognitive decline and stroke.
How similar studies have gone: Previous research showed a high rate of silent brain infarcts in iTTP survivors, supporting further multicenter study.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Chaturvedi, Shruti — Johns Hopkins University
- Study coordinator: Chaturvedi, Shruti
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Preventing silent brain infarcts in people who survived immune TTP
This project looks at whether finding and preventing small, symptom-free brain infarcts can protect thinking and lower stroke risk in adults who survived immune thrombotic thrombocytopenic purpura (iTTP).
-
Investigating how type I interferon helps restore blood-brain barrier function after a stroke
This study is looking at how a certain signaling process in the body can help repair the brain's protective barrier after a stroke, with the hope that the findings will lead to new ways to support recovery for stroke patients.
-
Improving brain health in patients with immune thrombotic thrombocytopenic purpura
This study is looking at how surviving a rare blood disorder called immune thrombotic thrombocytopenic purpura (iTTP) might affect brain health over time, especially focusing on hidden brain injuries that can happen without any noticeable symptoms, to help find ways to keep your brain healthy after treatment.
-
Erlangen Stroke Registry: A long-running look at stroke in a German community
This registry is testing how stroke cases are collected and followed over time in Erlangen to understand how many people are affected and how care evolves.
-
Early Identification of BAD-related Stroke in Adults
This study tests how well a multisource AI diagnostic approach can identify BAD-related stroke among adults with acute ischemic stroke within a week of onset.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.